Platelet Doubling After the First Azacitidine Cycle Is a Promising Predictor for Response in MDS, CMML and AML Patients in the Dutch Azacitidine Compassionate Patient Named Program
暂无分享,去创建一个
E. Vellenga | B. Biemond | G. Huls | M. Minnema | P. Wijermans | A. Beeker | B. Rees | N. Veeger | C. Alhan | F. D. Boer | M. Hoogendoorn | M. Schaafsma | E. Libourel | M. Eefting | J. Koedam | R. Brouwer | K. Jie | L. Helm | O. Weerdt | A. V. D. Loosdrecht | J. Wegman | M. Kooy | S. D. Bakker